Clinical trial

Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging

NCT07225114

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention contrast agent perflutren lipid Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention Ultrasound Imaging Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2025-11-04

PhasePHASE2

Conditions

Breast Cancerverified · MONDO: breast cancer

Kidney Neoplasmsunresolved

Liver Neoplasmsunresolved

Interventions

contrast agent perflutren lipidDRUG

Ultrasound ImagingDEVICE

Sponsors & collaborators

UNC Lineberger Comprehensive Cancer Centerlead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

Chapel HillNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07225114 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.